Pathways and mechanisms of N-acylethanolamine biosynthesis: Can anandamide be generated selectively?

Chemistry and Physics of Lipids

Volumn 108, Issue 1-2, 2000, Pages 71-87

  Schmid, Harald H O ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Anandamide; Mammals; N acyl PE; N acylethanolamine

Indexed keywords

ACYLTRANSFERASE; AMIDASE; ANANDAMIDE; CANNABINOID RECEPTOR; CERAMIDE; ETHANOLAMINE; ETHANOLAMINE DERIVATIVE; N ACYLETHANOLAMINE; N ACYLPHOSPHATIDYLETHANOLAMINE; PHOSPHODIESTERASE; UNCLASSIFIED DRUG;

ACYLATION; ARTICLE; BIOACCUMULATION; CELL LEVEL; CELL PROTECTION; HORMONE RECEPTOR INTERACTION; HUMAN; HYDROLYSIS; LIPOGENESIS; NONHUMAN; PRIORITY JOURNAL; REACTION ANALYSIS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALIA; MAMMALIA;

EID: 0033661740     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-3084(00)00188-2     Document Type: Review

References (104)

1. N-acylethanolamines as membrane topological stress compromising agents
2. Microsomal synthesis of fatty acid amides
3. Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N-arachidonoylphosphatidylethanolamine in SK-N-SH cells
4. Influence of fatty acid ethanolamides and Δ9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells
5. Effects of cannabinoid receptor ligands on LPS-induced pulmonary inflammation in mice
6. Stress-induced generation of N-acylethanolamines in mouse epidermal JB6 P + cells
7. + cells
8. Biosynthesis, uptake and degradation of anandamide and palmitoylethanolamide in leukocytes
9. Occurrence and metabolism of anandamide and related acyl-ethanolamides in ovaries of the sea urchin Paracentrotus lividus
10. Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells - Implications for cell proliferation and differentiation
11. Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina
12. A new class of phosphatides isolated from soft wheat flour
13. Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP
14. Membrane localization of N-acylphosphatidylethanolamine in central neurons: Studies with exogenous phospholipases
15. Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidyl-ethanolamine, in rat brain
16. Novel lipids of Butyrivibrio spp
17. Enzymatic formation of fatty acid amides of ethanolamine by rat liver microsomes
18. Chemical characterization of a family of brain lipids that induce sleep
19. Structural properties of lipids and their functional roles in biological membranes
20. N-acylphosphatidyl-ethanolamine, a phospholipid that is rapidly metabolized during the early germination of pea seeds
21. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines
22. Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization
23. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist
24. Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes
25. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
26. Endocannabinoids and other fatty acid derivatives with cannabimimetic properties: Biochemistry and possible physiopathological relevance
27. Formation and inactivation of endogenous cannabinoid anandamide in central neurons
28. Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells
29. Incorporation of N-acylethanolamine phospholipids into egg phosphatidylcholine vesicles: Characterization and permeability properties of the binary systems
30. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins
31. Identification of N-acylethanolamine phosphoglycerides and acylphosphatidylglycerol as the phospholipids which disappear as Dictyostelium discoideum cells aggregate
32. N-acylethanolamine accumulation in infarcted myocardium
33. Accumulation of N-acylethanolamine glycerophospholipids in infarcted myocardium
34. 2+ release from mitochondria by N-acylethanolamines, a class of lipids synthesized in ischemic heart tissue
35. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide
36. Glycerophospholipids in brain: Their metabolism, incorporation into membranes, functions, and involvement in neurological disorders
37. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction
38. Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat
39. Base-exchange reactions of the phospholipids in cardiac membranes
40. Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma
41. Anandamide amidohydrolase of porcine brain: cDNA cloning, functional expression and site-directed mutagenesis
42. Phosphatidyl-(N-acyl)-ethanolamine. A lipid component of mammalian epidermis
43. Dual effects of anandamide on NMDA receptor-mediated responses and neutrotransmission
44. Functions of ceramide in coordinating cellular responses to stress
45. Glutamate stimulates the formation of N-acylphosphatidylethanolamine and N-acylethanolamine in cortical neurons in culture
46. Characterization of glutamate-induced formation N-acylphosphatidylethanolamine and N-acylethanolamine in cultured neocortical neurons
47. Biochemistry and pharmacology of arachidonoylethanolamide, a putative endogenous cannabinoid
48. Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion
49. Characterization of the kinetics and distribution of N-arachidonyl-ethanolamine (anandamide) hydrolysis by rat brain
50. Direct evidence for essential role of sphingomyelinase in UV-induced activation of c-Jun N-terminal kinase
51. Phosphatidylinositol-3 kinase is necessary for 12-O-tetradecanoylphorbol-13-acetate-induced cell transformation and activated protein-1 activation
52. Distribution of anandamide amidohydrolase in rat tissues with special reference to small intestine
53. Isotope dilution mass spectrometric measurements indicate that arachidonoylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post mortem but is contained at low levels in or is absent from fresh tissue
54. Accumulation of various N-acylethanolamines including N-arachidonoylethanolamine (anandamide) in cadmium chloride-administered rat testis
55. Inhibitors of arachidonoyl ethanolamide hydrolysis
56. The ATP- and CoA-independent synthesis of arachidonoylethanolamide. A novel mechanism underlying the synthesis of the endogenous ligand of the cannabinoid receptor
57. The identification of N-(2-hydroxyethyl)-palmitamide as a naturally occurring anti-inflammatory agent
58. Differential turnover of phospholipid acyl groups in mouse peritoneal macrophages
59. Alterations of fatty acyl turnover in macrophage glycerolipids induced by stimulation. Evidence for enhanced recycling of arachidonic acid
60. Biosynthesis and turnover of anandamide and other N-acylethanolamines in peritoneal macrophages
61. Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma anandamide amidohydrolase
62. N-Palmitoylphosphatidylethanolamine stabilizes liposomes in the presence of human serum: Effect of lipidic composition and system characterization
63. On the biosynthesis and metabolism of N-acylethanolamine phospholipids in infarcted dog heart
64. N-Acylation of ethanolamine phospholipids in canine myocardium
65. Biosynthesis of N-acylethanolamine phospholipids by dog brain preparations
66. Catabolism of N-acylethanolamine phospholipids by dog brain preparations
67. Occurrence of N-acylethanolamine phospholipids in fish brain and spinal cord
68. N-acylethanolamine phospholipid metabolism in normal and ischemic rat brain
69. Phase behavior of synthetic N-acylethanolamine phospholipids
70. Identification of two serine residues involved in catalysis by fatty acid amide hydrolase
71. The uterus is a potential site of anandamide synthesis and hydrolysis: Differential profile of anandamide synthase and hydrolase activities in the mouse uterus during periimplantation period
72. Effects of long-chain N-acylethanolamines on lipid peroxidation in cardiac mitochondria
73. Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system
74. N-acylphosphatidylethanolamine-hydrolysing phospholipase D lacks the ability to transphosphatidylate
75. N-Acylation of dog heart ethanolamine phospholipids by transacylase activity
76. The role of cardiolipin as an acyl donor in N-acylethanolamine phospholipid biosynthesis
77. Properties of canine myocardial phosphatidylethanolamine N-acyltransferase
78. Characterization of CB2 receptors in spleen and mast cells
79. N-Acylation of dog heart ethanolamine phospholipids by acyl transfer does not involve hydrolysis
80. Metabolism of N-acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type
81. Hydrolysis of N-acylated phospholipids by phospholipases A2 and D: A method of identification and analysis
82. N-Acylated glycerophospholipids and their derivatives
83. Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain
84. Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain
85. The N-acylation-phosphodiesterase pathway and cell signalling
86. Anandamide and other N-acylethanolamines in mouse peritoneal macrophages
87. Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation
88. Generation and remodeling of highly polyunsaturated molecular species of rat hepatocyte glycerophospholipids
89. Alternative pathways of anandamide biosynthesis in rat testes
90. A sensitive endocannabinoid assay. The simultaneous analysis of N-acylethanolamines and 2-monoacylglycerols
91. Bioactive long chain N-acylethanolamines in five species of edible bivalve molluscs. Possible implications for mollusc physiology and sea food industry
92. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): Identification of cannabinoid receptor subtype selective ligands
93. The aliamide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons
94. Glycerophospho-(N-acyl)-ethanolamine lipids in degenerating BHK cells
95. N-oleoylethanolamine inhibits glucosylation of natural ceramides in CHP-100 neuroepithelioma cells: Possible implications for apoptosis
96. Ceramidase and ceramide synthesis in human kidney and cerebellum. Description of a new alkaline ceramidase
97. Enzymatic synthesis of anandamide, an endogenous cannabinoid receptor ligand, through N-acylphosphatidylethanolamine pathway in testis: Involvement of Ca2 + -dependent transacylase and phosphodiesterase activities
98. Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamide, an endogenous cannabinoid receptor ligand, in rat brain microsomes. Comparison with synthesis from free arachidonic acid and ethanolamine
99. Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds
100. Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells
101. Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide
102. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
103. Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock
104. Pain modulation by release of the endogenous cannabinoid anandamide